Gastroenterology Archives

Efficacy and health-related quality of life associated with second-line vedolizumab after first-line treatment with one anti-TNF in patients with ulcerative colitis: a meta-analysis of the GEMINI-1 and VISIBLE-1 trials

Authors: R Atreya, J Kirchgesner, Z Cheah, P Biedermann, L Bakker, M Meyer, T Raine Published: Therapeutic Advances in Gastroenterology, 2026 View publication Background Vedolizumab is a monoclonal antibody approved for adults...

Minimal criteria to screen for Wilson disease: A delphi consensus in the United States

Authors: J M Bronstein, R P Gonzalez-Peralta, M Lorincz, V Medici, S Diaz-Mendoza, K Pantiri Published: International Journal of Hepatology, 2025 View publication Objective The objective was to develop consensus on minimal...

Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: A retrospective cohort study

Authors: B Coxam, F Sheikh, H Kew, M Fraser, B Levick, C Rolfe, T Ellison, K G Pollock Published: BMJ Open, 2025 View publication Objectives Inflammatory bowel diseases (IBDs) and multiple sclerosis...

Terlipressin versus midodrine plus octreotide for hepatorenal sy-ndrome-acute kidney injury: A propensity score-matched comparison

Authors: S A Gonzalez, V V Chirikov, W-J Wang, X Huang, K Jamil, D A Simonetto Published: Clinical and translational gastroenterology, 2023 View publication Objectives Evidence on the comparison of treatments for...

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study

Authors: F Cummings, D R Gaya, S Levison, S Subramanian, G Owen, A Rathmell, F Glen, D Demuth, S Meadowcroft, P M Irving Published: Medicine, 2019 View publication Abstract Results from clinical...

Early versus later use of vedolizumab in IBD: patient characteristics and treatment patterns in the real world (RALEE)

Authors: M Kuharic, N Krugliak Cleveland, N Candela, J Carter, J Qian, N Rusibamayila, R Turpin, D Rubin Published: The American journal of gastroenterology, 2021 View publication Background Pivotal trials in inflammatory...

Development of the symptoms and impacts questionnaire for Crohn’s disease and ulcerative colitis

Authors: P S Dulai, V Jairath, R Khanna, C Ma, K P McCarrier, M L Martin, C E Parker, J Morris, B G Feagan, W J Sandborn Published: Alimentary pharmacology & therapeutics,...

Burden of irritable bowel syndrome in an increasingly cost-aware National Health Service

Authors: A Soubieres, P Wilson, A Poullis, J Wilkins, M Rance Published: BMJ, 2014 View publication Background The National Health Service (NHS) is faced with increasing cost pressures that make the efficient...

Impact of Infliximab-dyyb (Infliximab Biosimilar) on clinical and patient-reported outcomes: 1-year follow-up results from an observational real-world study among patients with inflammatory bowel disease in the US and Canada (the ONWARD Study)

Authors: B Abraham, B Eksteen, K Nedd, H Kale, D Patel, J Stephens, A Shelbaya, R Chambers & A Soonasra Published: Advances in Therapy, 2022 View publication Introduction To date, there are...

News